The Industry’s Only Networked Ecosystem for the Food & Beverage Supply Chain Sets New Milestones, Reinforces Position as Premier Integrated Compliance and Product Development Solution Provider WESTMINSTER, Colo., Jan. 19, 2024 /PRNewswire/ — TraceGains has emerged with record performance in a year marked by unprecedented challenges and opportunities within food supply chains. Today, the company announces… Continue reading TraceGains Marks Monumental 2023 with Accelerated Year-Over-Year Growth
Category: Newswire
China Matters’ Feature: How did Honolulu and Zhongshan create intertwining legacies?
BEIJING, Jan. 19, 2024 /PRNewswire/ — What do Honolulu and the city of Zhongshan thousands of miles away have in common? Why did these two seemingly unrelated places become sister cities in 1997? Continue Reading Discover the fascinating connection between Zhongshan and Honolulu It’s reported that 80% of Chinese and Chinese Americans living in Honolulu… Continue reading China Matters’ Feature: How did Honolulu and Zhongshan create intertwining legacies?
LOGO of China’s Hainan Coastal Scenic Highway Officially Released
HAIKOU, China, Jan. 19, 2024 /PRNewswire/ — Recently, China’s Hainan Free Trade Port officially released the LOGO of the Hainan Coastal Scenic Highway. Continue Reading Hainan Coastal Scenic Highway logo Named as “Pearl of the South China Sea”, the LOGO draws inspiration from Hainan elements, capturing the essence of the Highway’s unique charm – its integration with… Continue reading LOGO of China’s Hainan Coastal Scenic Highway Officially Released
NETA Auto Strategic Partner Conference 2024: Successful Global Collaboration for Future Development
SHANGHAI, Jan. 19, 2024 /PRNewswire/ — As the new year unfolded, the grand and momentous NETA Auto Strategic Partner Conference 2024 was successfully hosted. This conference, marking a crucial milestone in NETA Auto’s decade-long journey, has charted the course for the company’s global future, laying the groundwork for in-depth collaboration with worldwide suppliers and dealers. Continue… Continue reading NETA Auto Strategic Partner Conference 2024: Successful Global Collaboration for Future Development
Airbus chooses Sopra Steria to help optimise its engineering methods and tools
PARIS, Jan. 19, 2024 /PRNewswire/ — Sopra Steria, a major player in the European tech sector, has been selected, through its Aeroline vertical, to help European aeronautics giant Airbus modernise its engineering methods and tools. This strategic announcement bolsters Sopra Steria’s positioning as a key partner to the aeronautics sector. “Today, we’re proud to see… Continue reading Airbus chooses Sopra Steria to help optimise its engineering methods and tools
Global Online On-demand Home Services Market Report 2024: North America Leads Growth, Strategic Partnerships and Product Innovation on the Rise – Long-term Forecasts to 2028 and 2033
DUBLIN, Jan. 23, 2024 /PRNewswire/ — The “Online On-demand Home Services Global Market Report 2024” report has been added to ResearchAndMarkets.com’s offering. The global market for online on-demand home services has witnessed a notable surge, demonstrating a robust expansion from $4.64 billion in 2023 to a projected $5.29 billion in 2024, progressing at a compound annual growth rate… Continue reading Global Online On-demand Home Services Market Report 2024: North America Leads Growth, Strategic Partnerships and Product Innovation on the Rise – Long-term Forecasts to 2028 and 2033
Europe Pathogen or Plant Disease Detection and Monitoring Market: Projected Growth in Controlled Environment Agriculture, Comprehensive Analysis 2023-2028
DUBLIN, Jan. 23, 2024 /PRNewswire/ — The “Europe Pathogen or Plant Disease Detection and Monitoring Market: Analysis and Forecast, 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The recently published market research report, which analyzes the vital segments of pathogen and plant disease detection and monitoring within the European territory (excluding U.K.), has unveiled an expected Compound Annual… Continue reading Europe Pathogen or Plant Disease Detection and Monitoring Market: Projected Growth in Controlled Environment Agriculture, Comprehensive Analysis 2023-2028
CDNetworks Successfully Mitigated a Blockchain DDoS Attack, Peaking at 1.025 Tbps, on the Eve of Bitcoin ETF Approval
SINGAPORE, Jan. 23, 2024 /PRNewswire/ — CDNetworks, the APAC-leading network to deliver edge as a service, successfully detected and shielded a cryptocurrency exchange from a relentless Blockchain DDoS attack that occurred on January 9, 2024, which peaked at 1.025Tbps. Coincidentally, the attack occurred on the day before the U.S. SEC approved the first U.S.-listed Bitcoin Exchange-traded… Continue reading CDNetworks Successfully Mitigated a Blockchain DDoS Attack, Peaking at 1.025 Tbps, on the Eve of Bitcoin ETF Approval
PharmAbcine Announces First Patient Dosed in Phase 1a/b Clinical Trial of PMC-309 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced or Metastatic Solid Tumors
Initiation of Phase 1a/b clinical trial exploring MTD, RP2D, safety and tolerability of PMC-309 monotherapy and combination therapy with KEYTRUDA® The clinical trial aims to enroll a total of 67 patients across four institutions in Australia DAEJEON, South Korea, Jan. 23, 2024 /PRNewswire/ — PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on next-generation… Continue reading PharmAbcine Announces First Patient Dosed in Phase 1a/b Clinical Trial of PMC-309 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced or Metastatic Solid Tumors
Sciwind Biosciences Announces Positive Results from Phase 1 Clinical Trial of XW004, an Oral Formulation of Long-acting GLP-1 Analog Ecnoglutide
Oral ecnoglutide was safe and well tolerated with gastrointestinal side effects as the most commonly reported adverse events Study participants receiving up to 30 mg oral ecnoglutide once-daily for 6 weeks achieved a mean body weight reduction of -6.8% from baseline, compared to -0.9% for the placebo group The study remains ongoing to evaluate additional dosing regimens… Continue reading Sciwind Biosciences Announces Positive Results from Phase 1 Clinical Trial of XW004, an Oral Formulation of Long-acting GLP-1 Analog Ecnoglutide